Erratum to Prevalence and clinical significance of pathogenic germline <i>BRCA1/2</i> mutations in Chinese non-small cell lung cancer patients
Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu, Chengping Hu
Abstract
In the published article[1][1], the affiliation for the first author, Xingsheng Hu, is “Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences”, we would like to update it to “Department of Medical Oncology, National Cancer Center/National Clinical Research Center
Topics & Concepts
Lung cancerMedicineClinical OncologyInternal medicineOncologyCenter (category theory)Family medicineMedical scienceCancerMedical educationCrystallographyChemistryBRCA gene mutations in cancerPARP inhibition in cancer therapyDNA Repair Mechanisms